Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Empagliflozin	129
Overall Study	STARTED	Other SGLT-2i	3,926
Overall Study	STARTED	Dipeptidyl Peptidase-4 Inhibitors (DPP-4i)	6,416
Overall Study	STARTED	Metformin	14,007
Overall Study	STARTED	Sulfonylureas (SU)	6,079
Overall Study	STARTED	Glucagon-like Peptide-1 (GLP-1) Agonists	1,351
Overall Study	COMPLETED	Empagliflozin	129
Overall Study	COMPLETED	Other SGLT-2i	3,926
Overall Study	COMPLETED	Dipeptidyl Peptidase-4 Inhibitors (DPP-4i)	6,416
Overall Study	COMPLETED	Metformin	14,007
Overall Study	COMPLETED	Sulfonylureas (SU)	6,079
Overall Study	COMPLETED	Glucagon-like Peptide-1 (GLP-1) Agonists	1,351
Overall Study	NOT COMPLETED	Empagliflozin	0
Overall Study	NOT COMPLETED	Other SGLT-2i	0
Overall Study	NOT COMPLETED	Dipeptidyl Peptidase-4 Inhibitors (DPP-4i)	0
Overall Study	NOT COMPLETED	Metformin	0
Overall Study	NOT COMPLETED	Sulfonylureas (SU)	0
Overall Study	NOT COMPLETED	Glucagon-like Peptide-1 (GLP-1) Agonists	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03050619/flow